The news that Facebook and Instagram owner Meta has bought Moltbook – a “social network for AI agents” - seems like just another of those breathless endless announcements in the race for dominance in ...
Researchers say they have uncovered a takedown-resistant botnet of 14,000 routers and other network devices—primarily made by ...
Abstract: Power transformers are vital for transmitting, distributing, and using energy produced in electrical energy systems. The failure of a distribution transformer can cause significant financial ...
In a report released yesterday, Patrick Dolezal from LifeSci Capital maintained a Buy rating on Structure Therapeutics, Inc. Sponsored ADR, with a price target of $107.00. The company’s shares closed ...
Overview Artificial intelligence seems to be transforming drug discovery in 2026, enabling faster molecule design, smarter clinical trials, and reduced R&D ...
Need a quote from a Motley Fool analyst? Over the past decade, Recursion Pharmaceuticals, Inc. has built something truly special: a differentiated platform pioneering the integration of large-scale ...
Guidance extended from year-end 2027 to early 2028, with operating expense reduction targets reiterated and achieved at a greater scale (now 35% year-over-year, 10% below guidance). Strategic focus ...
Recursion (NASDAQ:RXRX) reported fourth-quarter 2025 revenue of $35.5 million on Wednesday, significantly exceeding analyst estimates of $24.6 million. The performance was driven by the timing of ...
Abstract: The cybersecurity of microgrid has received widespread attentions due to the frequently reported attack accidents against distributed energy resource (DER) manufactures. Numerous impact ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results